Previous studies by Pan and colleagues [11] indicated that the sensitivity of a panel of AML cell lines to ABT199 (based on IC50 values) correlated with their levels of BCL2 protein, whereas BCL-xL protein levels were inversely correlated with ABT199 sensitivity. The gene discussed is BCL2; the disease is acute myeloid leukemia.